Company Filing History:
Years Active: 2015-2020
Title: Reinhard Schneppenheim: Innovator in Hematology
Introduction
Reinhard Schneppenheim is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of hematology, particularly in the study and determination of von Willebrand factor activity. With a total of 4 patents to his name, his work has had a substantial impact on medical diagnostics.
Latest Patents
Schneppenheim's latest patents include innovative methods and kits for determining von Willebrand factor activity in the absence of ristocetin. These patents describe various methods, kits, and reagents designed to accurately assess von Willebrand factor (VWF) activity in samples without the need for ristocetin, enhancing diagnostic capabilities in clinical settings.
Career Highlights
Reinhard Schneppenheim is associated with Siemens Healthcare Diagnostics Products GmbH, where he applies his expertise to develop advanced diagnostic solutions. His work has been instrumental in improving the understanding and management of bleeding disorders related to von Willebrand factor.
Collaborations
Some of his notable coworkers include Harald Althaus and Tobias Obser, with whom he has collaborated on various projects aimed at advancing hematological diagnostics.
Conclusion
Reinhard Schneppenheim's contributions to the field of hematology through his patents and work at Siemens Healthcare Diagnostics Products GmbH highlight his role as an innovator in medical diagnostics. His efforts continue to influence the way von Willebrand factor activity is assessed, ultimately benefiting patient care.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.